Schema therapy with exposure and response prevention for the treatment of chronic anxiety with comorbid personality disorder.

CONCLUSIONS: The combination of ST and exposure with response prevention may be a viable avenue for research and treatment for this subpopulation. However, further research is needed to confirm and enhance effectiveness and identify working mechanisms of SCHerp. PRACTITIONER POINTS: The SCHerp programme combines schema therapy with exposure and response prevention to tackle chronic anxiety in patients with comorbid personality disorder SCHerp significantly reduced psychological malfunction and maladaptive modes, and increased adaptive modes Changes in schema modes correlated with changes in psychological malfunction, suggesting that schema modes are an appropriate treatment target in this population No active control group was included so no therapy-specific factors can be determined at this stage. PMID: 33319395 [PubMed - as supplied by publisher]
Source: The British Journal of Clinical Psychology - Category: Psychiatry & Psychology Authors: Tags: Br J Clin Psychol Source Type: research